Cytokinetics | Passivo Circulante





Passivo Circulante Alterar Data
Acadia Pharmaceuticals USD 356.58M 26.56M 2025-09
Amgen USD 25.49B 3.7B 2025-12
Arca Biopharma USD 20.97M 8.86M 2025-09
Bayer EUR 28.96B 825M 2025-09
Biogen USD 3.35B 59.4M 2025-12
Brainstorm Cell Therapeutics USD 9.02M 495K 2025-09
Bristol-Myers Squibb USD 28.14B 608M 2025-09
Capricor Therapeutics USD 28.15M 249K 2025-09
Cytokinetics USD 142.14M 11.08M 2025-09
Eisai JPY 387.67B 9.42B 2025-12
Eli Lilly USD 35.23B 4.91B 2025-12
Exelixis USD 405.64M 31.86M 2025-12
Geron USD 87.71M 23.43M 2025-09
Halozyme Therapeutics USD 177.09M 660.14M 2025-12
Ionis Pharmaceuticals USD 903.46M 6.22M 2025-09
Ligand Pharmaceuticals USD 30.54M 34.2M 2025-09
Merck USD 28.63B 2.59B 2025-09
Novartis USD 32B 286M 2025-09
Pfizer USD 36.6B 1.13B 2025-09
Regeneron Pharmaceuticals USD 4.37B 56.7M 2025-12
Roche Holding CHF 28B 421M 2025-12
Sanofi EUR 28.35B 3.76B 2025-12


Cytokinetics Passivo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.